Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nuvation Bio
Biotech
John Cox gets new biotech CEO gig at Dyne—Chutes & Ladders
Cox named new CEO of Dyne. Ex-Madrigal US sales chief named CCO of Nuvation. Longtime NIAID leader leaves for CSO gig at Alphabet's Calico.
Max Bayer
,
Gabrielle Masson
Mar 29, 2024 9:30am
Nuvation drops tumor asset and reduces staff by a third
Aug 1, 2022 9:35am
Roche taps new CEO—Chutes & Ladders
Jul 22, 2022 9:30am
Nuvation's new solid tumor focus hits snag on FDA hold
Jun 27, 2022 10:05am
Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders
Jun 3, 2022 9:30am
Moneybags Nuvation deprioritizes 2 solid tumor prospects
May 10, 2022 9:13am